Great thoughts and work.
The question herein revolves around WHY a company just starting out would do this to itself and its retail investors, chosing a funding vehicle (a R/Split) that damages its image in the market place? $$s to continue you might say. However the rationale may be . . this is rather much a developmental stage company (that is the image DRIO has cast around itself). I suspect many retail investors had felt DRIO was some ways past that status, and right on verge of becoming a force in mobile medical readers. Funding past March 2015 is vapour in the morning sunrise . . . where is the USA governmental interest in DRIO bodily fluids readers potential to expand medical tech and cost containment advantages?
There is no real prospect (apparently) of DRIO getting FDA approval in rest of 2014.
Not with the announcement that they just sent a mass cold form letter of advertisement to USA doctors. The USA PR campaign has barely started (any such campaign is just the side effect of internet chatter, etc. to this date). Company (DRIO) has given us no evidence of any contacts with USA medical players (except perhaps some USA players showed up at the CC).
Insufficient data of DRIO mobile readers users appears to be the impediment to FDA Approval? I might be wrong in my thoughts herein, yet all we have from DRIO is something to the effect, that FDA and us are in stead contact. My guessimate is FDA will need 6-12 months of user datum to gauge before it can feel safe in approving the DRIO reader. Further; the volume of the stock (as you have mentioned and Pennystock) is appropriate for company DRIO, some of the private placement, and market maker support of stock price. Its doubtful at this stage many retail investors remain in the stock, and the daily stock volume transaction clusters bespeak no overwhelming trading being done by retail day-traders.
I too foresee token' accounting in the fore coming company quarterly, of some level of revenues being posted (to boost up retail investors).
I would love to be wrong to project little up price effect will result, until we get FDA approval. And, if Pennystock is truly 90-95% accurate in his TA and candle ash reading . . . should there not be a ready employer of big guns pounding on his door?
George Soros and Warren and The Biker Investor Rogers hardly could match such performance.
